Related Experiment Video
Updated: Feb 11, 2026

Detection of Lung Tumor Progression in Mice by Ultrasound Imaging
Published on: February 27, 2020
Recent progress in systemic treatment for lung cancer
Jeffrey W Clark1, Dan L Longo2
1Harvard Medical School, Massachusetts General Hospital.
Purpose Of Review:
We intend to highlight progress made in 2017 to lung cancer molecular nosology and application of new knowledge to treatment.
Recent Findings:
Studies have shown that agents targeting specific molecular defects in lung cancers such as epidermal growth factor receptor(egfr) mutations, alk or ros1 gene rearrangements, are more effective than conventional combination chemotherapy as primary treatment for various lung cancer subgroups. Identification of mechanisms of drug resistance has guided development of improved agents and effective salvage regimens. Progress in reversing tumor-induced immunosuppression has led to further improvements in response rates (RR) including some patients with prolonged durable remissions.
Summary:
State-of-the-art management of patients with lung cancer requires information derived from tumor molecular analysis, obtained either directly from the tumor or from tumor-derived circulating DNA. Empiric combination chemotherapy is no longer uniformly the best available treatment for all patients. Therapeutic decisions should be guided by an understanding of molecular features of an individual patient's tumor. The future gains will likely emerge from finding optimal ways of combining targeted therapy, immunotherapy, and chemotherapy.
Insights
Molecular profiling of lung cancer has advanced treatment. Targeted therapies and immunotherapies show improved effectiveness over traditional chemotherapy for specific patient subgroups.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Lung cancer treatment has historically relied on chemotherapy.
- Recent advancements focus on understanding the molecular underpinnings of lung cancer.
- Personalized medicine approaches are transforming patient care.
Purpose of the Study:
- To review progress in lung cancer molecular nosology in 2017.
- To discuss the application of new molecular knowledge to lung cancer treatment strategies.
Main Methods:
- Review of recent scientific literature and clinical studies.
- Analysis of data on targeted therapies and immunotherapies.
- Evaluation of molecular profiling techniques for lung cancer diagnosis.
Main Results:
- Targeted agents for specific molecular defects (e.g., EGFR mutations, ALK/ROS1 rearrangements) demonstrate superior efficacy compared to conventional chemotherapy.
- Understanding drug resistance mechanisms has led to improved therapeutic agents and salvage regimens.
- Advances in reversing tumor-induced immunosuppression have enhanced response rates and durable remissions.
Conclusions:
- Tumor molecular analysis is essential for state-of-the-art lung cancer management.
- Treatment decisions should be informed by individual tumor molecular features.
- Future progress lies in combining targeted therapy, immunotherapy, and chemotherapy.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
05:11Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs
Published on: May 10, 2024
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Treatment Resistant Cancers
Lung Capacity
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Second Order systems II
First Order Systems
When a first-order system is subjected to a unit-step input, its response is characterized by its transfer function. By applying the Laplace transform of the unit-step input to the transfer function, expanding the...